Treatment of paroxysmal supraventricular tachycardia with adenosine: Implications for nursing

A. L. Severson, L. T. Meyer

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Paroxysmal supraventricular tachycardia (PSVT) is a frequently occurring arrhythmia. Currently, verapamil and manual vagal stimulation are the first- line interventions for PSVT. Although verapamil is widely used for the treatment of PSVT, it can result in hypotension and ventricular fibrillation if given to a patient with ventricular tachycardia. Because the differential diagnosis of broad QRS complex tachycardia is difficult, the development of a safer drug for the treatment of both narrow- and broad-complex tachycardia is extremely important. Adenosine is a promising new drug for the treatment of PSVT. Its use is reviewed in three presentations.

Original languageEnglish (US)
Pages (from-to)350-356
Number of pages7
JournalHeart and Lung: Journal of Critical Care
Volume21
Issue number4
StatePublished - Jan 1 1992

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Treatment of paroxysmal supraventricular tachycardia with adenosine: Implications for nursing'. Together they form a unique fingerprint.

  • Cite this